Itai Danovitch

Science 37, Inc. develops mobile technology, clinical trials and patient-centric models for clinical research. It focuses on the development of networked patient-centric models for clinical research to accelerate biomedical discovery. The firm develops Network Oriented Research Assistant, which bridges the gap between traditional trial management software and an advanced telemedicine platform; supports end-to-end management of networked clinical trials; and allows researchers to communicate with patients and mobile nurses from homes using videos, photographs, survey forms, or device data capture on iPhones, iPads, or Android devices. The company was founded by Noah Craft and Belinda Tan and is headquartered in Culver City, CA.

Science 37, Inc. develops mobile technology, clinical trials and patient-centric models for clinical research. It focuses on the development of networked patient-centric models for clinical research to accelerate biomedical discovery. The firm develops Network Oriented Research Assistant, which bridges the gap between traditional trial management software and an advanced telemedicine platform; supports end-to-end management of networked clinical trials; and allows researchers to communicate with patients and mobile nurses from homes using videos, photographs, survey forms, or device data capture on iPhones, iPads, or Android devices. The company was founded by Noah Craft and Belinda Tan and is headquartered in Culver City, CA.

Science 37, Inc. develops mobile technology, clinical trials and patient-centric models for clinical research. It focuses on the development of networked patient-centric models for clinical research to accelerate biomedical discovery. The firm develops Network Oriented Research Assistant, which bridges the gap between traditional trial management software and an advanced telemedicine platform; supports end-to-end management of networked clinical trials; and allows researchers to communicate with patients and mobile nurses from homes using videos, photographs, survey forms, or device data capture on iPhones, iPads, or Android devices. The company was founded by Noah Craft and Belinda Tan and is headquartered in Culver City, CA.

Bexson Biomedical, Inc. is a research stage company based in Santa Barbara, CA. The company is focused on developing BB106, a ketamine therapy for pain management and mental health disorders. The company is also applying their proprietary delivery platform to several psychedelic and non-psychedelic compounds to reduce suffering caused by pain, addiction, and mental health conditions. The company was founded by Jeffrey Becker and Gregg Peterson has been the CEO of the company since 2019.

Science 37, Inc. develops mobile technology, clinical trials and patient-centric models for clinical research. It focuses on the development of networked patient-centric models for clinical research to accelerate biomedical discovery. The firm develops Network Oriented Research Assistant, which bridges the gap between traditional trial management software and an advanced telemedicine platform; supports end-to-end management of networked clinical trials; and allows researchers to communicate with patients and mobile nurses from homes using videos, photographs, survey forms, or device data capture on iPhones, iPads, or Android devices. The company was founded by Noah Craft and Belinda Tan and is headquartered in Culver City, CA.

Bexson Biomedical, Inc. is a research stage company based in Santa Barbara, CA. The company is focused on developing BB106, a ketamine therapy for pain management and mental health disorders. The company is also applying their proprietary delivery platform to several psychedelic and non-psychedelic compounds to reduce suffering caused by pain, addiction, and mental health conditions. The company was founded by Jeffrey Becker and Gregg Peterson has been the CEO of the company since 2019.